RNPC3 and neoplasm: We found increased CD4+ and CD8+ T cell accumulation at the tumor sites of mice treated with Trunc‐LMP2A‐RNP, followed by those treated with FL‐LMP2A‐RNP (Figure S10, Supporting Information).